Silence Therapeutics (SLN) Asset Utilization Ratio (2024 - 2026)

Silence Therapeutics has disclosed Asset Utilization Ratio across 3 years of filings, most recently posting 0.01 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.01, down 95.37% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01 (down 95.37% YoY), and the FY2025 annual result was 0.0, down 98.75% from the prior year.
• Asset Utilization Ratio came in at 0.01 for Q1 2026 at Silence Therapeutics, up from 0.0 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.27 in Q4 2024 to a low of 0.0 in Q4 2025.
• The 3-year median for Asset Utilization Ratio is 0.15 (2025), against an average of 0.12.
• Across the five-year window, Asset Utilization Ratio tumbled 98.58% in 2025 and tumbled 95.37% in 2026, its largest moves.
• Silence Therapeutics' Asset Utilization Ratio stood at 0.27 in 2024, then sank by 98.58% to 0.0 in 2025, then jumped by 71.9% to 0.01 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.01 (Q1 2026), 0.0 (Q4 2025), and 0.17 (Q3 2025), per Business Quant data.